Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AngioDynamics Inc | ANGO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.87 | 07:00:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.87 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 5.26 - 11.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 5.87 | USD |
AngioDynamics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 233.95M | 39.86M | - | 338.75M | -52.44M | -1.32 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AngioDynamics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANGO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.35 | 6.395 | 5.83 | 6.10 | 516,950 | -0.48 | -7.56% |
| 1 Month | 5.73 | 7.52 | 5.73 | 6.47 | 789,738 | 0.14 | 2.44% |
| 3 Months | 5.94 | 7.52 | 5.26 | 6.09 | 533,173 | -0.07 | -1.18% |
| 6 Months | 6.56 | 8.25 | 5.26 | 6.41 | 548,333 | -0.69 | -10.52% |
| 1 Year | 8.86 | 11.38 | 5.26 | 7.30 | 548,340 | -2.99 | -33.75% |
| 3 Years | 25.07 | 32.00 | 5.26 | 13.53 | 381,994 | -19.20 | -76.59% |
| 5 Years | 20.62 | 32.00 | 5.26 | 13.97 | 336,892 | -14.75 | -71.53% |
AngioDynamics Description
| AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, it derives a majority of revenue from the United States. |
